Canaccord Genuity initiates coverage on Orthofix Medical with a Buy rating and $24 price target, citing growth potential and strong financial outlook.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback